Plain-English translation of NCT06681259 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a large research study that brings together patient information and biological samples from people diagnosed with gestational trophoblastic neoplasia (a rare pregnancy-related condition) across multiple hospitals in China. By collecting detailed medical records, blood and tissue samples, and tracking how patients respond to treatment over time, researchers hope to better understand which patients may be harder to treat and develop more personalized approaches to care.
Currently, some patients with gestational trophoblastic neoplasia don't respond well to standard chemotherapy, but doctors don't have reliable ways to predict who will struggle or how to adjust treatment accordingly. This study aims to identify the patterns and risk factors that make the condition harder to treat, so future patients can receive more targeted and effective care from the start.
You likely qualify if…
You likely don't qualify if…
If you join, you will share your medical history, undergo physical exams, and allow researchers to collect blood and tissue samples. You will also share information about your treatment plan, how you respond to therapy, and any side effects you experience. After treatment ends, you will be followed up periodically so researchers can check your hCG levels, imaging results, fertility status, and whether the condition has returned.
AI-generated summary from trial data · Aug 30, 2026 · Not medical advice
China